Health Anteris’ DurAVR THV Demonstrates 1% Heart Failure Hospitalization, Single-Digit Gradients and No Valve-Related Deaths at 1 Year in Patients with Small Aortic Annuli November 22, 2026
Health Surgery Partners, Inc. Announces Expiration and Results of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032 November 21, 2026
Health Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term November 19, 2026
Health Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium November 18, 2026
Health Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case November 18, 2026
Health Medline Inc. announces pricing of secondary offering of Class A common stock November 18, 2026
Health Novartis showcases hematology momentum and continued breast cancer leadership at ASH and SABCS November 18, 2026
Health Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update November 17, 2026
Health Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR) November 17, 2026